Zunpeng Liu
Weiqi Zhang
Wei Li
Zeming Wu
Wei Wang
Ruotong Ren
Yao Su
Peichang Wang
Liang Sun
Zhenyu Ju
Piu Chan
Moshi Song
Jing Qu
Guang-Hui Liu
1 Advanced Innovation Center for Human Brain Protection, National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, Beijing 100053, China;
2 National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China;
3 State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China;
4 State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China;
5 University of Chinese Academy of Sciences, Beijing 100049, China;
6 Institute of Stem cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China;
7 Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou 510632, China;
8 The MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
Funds: This work was supported by the National Key Research and Development Program of China (2017YFA0103304), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16010100), the National Key Research and Development Program of China (2015CB964800, 2017YFA0102802, 2014CB910503 and 2018YFA0107203), the National High Technology Research and Development Program of China (2015AA020307), the National Natural Science Foundation of China (Grant Nos. 31671429, 91749202, 91749123, 81625009, 81330008, 81371342, 81471414, 81422017, 81601233, 81671377, 31601109, 31601158, 81771515 and 81701388), Program of Beijing Municipal Science and Technology Commission (Z151100003 915072), Key Research Program of the Chinese Academy of Sciences (KJZDEW-TZ-L05), Beijing Municipal Commission of Health and Family Planning (PXM2018_026283_000002), and Advanced Innovation Center for Human Brain Protection (117212).
Received Date: 2018-03-12
Abstract
Abstract
Aging increases the risk of various diseases. The main goal of aging research is to find therapies that attenuate aging and alleviate aging-related diseases. In this study, we screened a natural product library for geroprotective compounds using Werner syndrome (WS) human mesenchymal stem cells (hMSCs), a premature aging model that we recently established. Ten candidate compounds were identified and quercetin was investigated in detail due to its leading effects. Mechanistic studies revealed that quercetin alleviated senescence via the enhancement of cell proliferation and restoration of heterochromatin architecture in WS hMSCs. RNA-sequencing analysis revealed the transcriptional commonalities and differences in the geroprotective effects by quercetin and Vitamin C. Besides WS hMSCs, quercetin also attenuated cellular senescence in Hutchinson-Gilford progeria syndrome (HGPS) and physiological-aging hMSCs. Taken together, our study identifies quercetin as a geroprotective agent against accelerated and natural aging in hMSCs, providing a potential therapeutic intervention for treating age-associated disorders.Keywords: Quercetin,
Stem cell,
Aging,
Werner syndrome,
Hutchinson-Gilford progeria syndrome
PDF全文下载地址:
http://www.protein-cell.org/article/exportPdf?id=88c75cb7-3c80-4534-804e-1f0346efff96&language=en